{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:09:48Z","timestamp":1782950988341,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.sleep.2025.106633","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:14:15Z","timestamp":1749654855000},"page":"106633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The putative effects of orexin receptor antagonists on pain and sleep in humans: A systematic review"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-5916","authenticated-orcid":false,"given":"Alberto","family":"Herrero Babiloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sangalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Javier","family":"Puertas-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibele Dal","family":"Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10289","key":"10.1016\/j.sleep.2025.106633_bib1","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.sleep.2025.106633_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00702-019-02067-z","article-title":"Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship","volume":"127","author":"Herrero Babiloni","year":"2020","journal-title":"J Neural Transm"},{"issue":"12","key":"10.1016\/j.sleep.2025.106633_bib3","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jpain.2013.08.007","article-title":"The association of sleep and pain: an update and a path forward","volume":"14","author":"Finan","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.sleep.2025.106633_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101459","article-title":"Multitargeting the sleep-pain interaction with pharmacological approaches: a narrative review with suggestions on new avenues of investigation","volume":"59","author":"Herrero Babiloni","year":"2021","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.sleep.2025.106633_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/j.pain.0000000000002124","article-title":"Towards the endotyping of the sleep-pain interaction: a topical review on multitarget strategies based on phenotypic vulnerabilities and putative pathways","volume":"162","author":"Herrero","year":"2021","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.sleep.2025.106633_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.46747\/cfp.6803179","article-title":"PEER simplified chronic pain guideline: management of chronic low back, osteoarthritic, and neuropathic pain in primary care","volume":"68","author":"Korownyk","year":"2022","journal-title":"Can Fam Physician"},{"issue":"2","key":"10.1016\/j.sleep.2025.106633_bib7","first-page":"307","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med : JCSM : official publication of the American Academy of Sleep Medicine"},{"key":"10.1016\/j.sleep.2025.106633_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.sleep.2018.05.023","article-title":"Sleep disturbances and sleep disorders in adults living with chronic pain: a meta-analysis","volume":"52","author":"Mathias","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.106633_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101573","article-title":"The efficacy and safety of dual orexin receptor antagonists in primary insomnia: a systematic review and network meta-analysis","volume":"61","author":"Xue","year":"2022","journal-title":"Sleep Med Rev"},{"issue":"7","key":"10.1016\/j.sleep.2025.106633_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40265-023-01859-8","article-title":"The comparative effectiveness and safety of insomnia drugs: a systematic review and network meta-analysis of 153 randomized trials","volume":"83","author":"Pan","year":"2023","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.sleep.2025.106633_bib11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/med.21959","article-title":"Targeting orexin receptors: recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders","volume":"43","author":"Bonifazi","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1016\/j.sleep.2025.106633_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112650","article-title":"Coregulation of sleep-pain physiological interplay by orexin system: an unprecedented review","volume":"391","author":"Ahmadi-Soleimani","year":"2020","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"4","key":"10.1016\/j.sleep.2025.106633_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"5 Suppl","key":"10.1016\/j.sleep.2025.106633_bib15","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0893-133X(01)00317-7","article-title":"A brief history of hypocretin\/orexin and narcolepsy","volume":"25","author":"Siegel","year":"2001","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.sleep.2025.106633_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pbb.2015.07.010","article-title":"Orexin type 1 receptor antagonism in rat locus coeruleus prevents the analgesic effect of intra-LC met-enkephalin microinjection","volume":"136","author":"Mohammad Ahmadi","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1515\/biol-2021-0001","article-title":"Research progress on the mechanism of orexin in pain regulation in different brain regions","volume":"16","author":"Kang","year":"2021","journal-title":"Open Life Sci"},{"key":"10.1016\/j.sleep.2025.106633_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2017.03.053","article-title":"A review of the role of orexin system in pain modulation","volume":"90","author":"Razavi","year":"2017","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"5","key":"10.1016\/j.sleep.2025.106633_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14737175.2024.2328728","article-title":"Orexins and primary headaches: an overview of the neurobiology and clinical impact","volume":"24","author":"Stanyer","year":"2024","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.sleep.2025.106633_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2025.106633_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neubiorev.2021.08.004","article-title":"Circadian rhythms and pain","volume":"129","author":"Bumgarner","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.sleep.2025.106633_bib22","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"key":"10.1016\/j.sleep.2025.106633_bib24","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.sleep.2025.106633_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"key":"10.1016\/j.sleep.2025.106633_bib26","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.sleep.2025.106633_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cegh.2023.101484","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clinical Epidemiology and Global Health"},{"issue":"3","key":"10.1016\/j.sleep.2025.106633_bib28","first-page":"415","article-title":"Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo","volume":"16","author":"Roehrs","year":"2020","journal-title":"J Clin Sleep Med : JCSM : official publication of the American Academy of Sleep Medicine"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AJP.0000000000000503","article-title":"Orexin receptor antagonism in painful diabetic neuropathy: a phase 2 trial with filorexant","volume":"34","author":"Joseph","year":"2018","journal-title":"Clin J Pain"},{"issue":"5","key":"10.1016\/j.sleep.2025.106633_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0333102414544979","article-title":"Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis","volume":"35","author":"Chabi","year":"2015","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.sleep.2025.106633_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/pm\/pnad126","article-title":"Improvement of sleep and pain with lemborexant administration in patients with chronic pain: a retrospective observational study","volume":"25","author":"Ueno","year":"2024","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.sleep.2025.106633_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12782","article-title":"Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications","volume":"28","author":"Herring","year":"2019","journal-title":"J Sleep Res"},{"issue":"5","key":"10.1016\/j.sleep.2025.106633_bib33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejpain.2006.09.008","article-title":"Self-reported pain sensitivity: lack of correlation with pain threshold and tolerance","volume":"11","author":"Edwards","year":"2007","journal-title":"Eur J Pain"},{"issue":"9","key":"10.1016\/j.sleep.2025.106633_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.pain.2013.05.031","article-title":"Relationship between quantitative sensory testing and pain or disability in people with spinal pain-a systematic review and meta-analysis","volume":"154","author":"Hubscher","year":"2013","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.sleep.2025.106633_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpain.2004.06.003","article-title":"Comparison of experimental and acute clinical pain responses in humans as pain phenotypes","volume":"5","author":"Kim","year":"2004","journal-title":"J Pain"},{"issue":"2","key":"10.1016\/j.sleep.2025.106633_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejpain.2006.02.001","article-title":"The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome","volume":"11","author":"Geisser","year":"2007","journal-title":"Eur J Pain"},{"issue":"9","key":"10.1016\/j.sleep.2025.106633_bib37","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/j.pain.0000000000000241","article-title":"Reporting of IMMPACT-recommended core outcome domains among trials assessing opioids for chronic non-cancer pain","volume":"156","author":"Mulla","year":"2015","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2025.106633_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.sleep.2025.106633_bib39","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1097\/j.pain.0000000000001952","article-title":"Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations","volume":"161","author":"Smith","year":"2020","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.sleep.2025.106633_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00702-019-02067-z","article-title":"Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship","volume":"127","author":"Herrero Babiloni","year":"2020","journal-title":"J Neural Transm"},{"issue":"45","key":"10.1016\/j.sleep.2025.106633_bib41","doi-asserted-by":"crossref","first-page":"E10720","DOI":"10.1073\/pnas.1807991115","article-title":"Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2025.106633_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(00)00470-X","article-title":"Orexin-A, an hypothalamic peptide with analgesic properties","volume":"92","author":"Bingham","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.sleep.2025.106633_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171007","article-title":"The role of orexin neuron activity in sleep\/wakefulness regulation","volume":"165","author":"Hung","year":"2023","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.sleep.2025.106633_bib44","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ejp.833","article-title":"Differential contribution of orexin receptors within the ventral tegmental area to modulation of persistent inflammatory pain","volume":"20","author":"Ezzatpanah","year":"2016","journal-title":"Eur J Pain"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib45","first-page":"77","article-title":"Orexin receptor antagonists as adjunct drugs for the treatment of depression: a mini meta-analysis","volume":"61","author":"Ugurlu","year":"2024","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.sleep.2025.106633_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jad.2024.12.008","article-title":"Efficacy of orexin antagonists for the management of major depressive disorder: a systematic review of randomized clinical trials","volume":"372","author":"Meshkat","year":"2025","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.sleep.2025.106633_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/AJP.0000000000000260","article-title":"A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption","volume":"32","author":"Boakye","year":"2016","journal-title":"Clin J Pain"},{"issue":"4","key":"10.1016\/j.sleep.2025.106633_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa2301940","article-title":"Oral orexin receptor 2 agonist in narcolepsy type 1","volume":"389","author":"Dauvilliers","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2025.106633_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171051","article-title":"The present and future of synthetic orexin receptor agonists","volume":"167","author":"Saitoh","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.sleep.2025.106633_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2014.03.043","article-title":"Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization","volume":"269","author":"Cady","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.sleep.2025.106633_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2016.01.031","article-title":"The role of trigeminal nucleus caudalis orexin 1 receptors in orofacial pain transmission and in orofacial pain-induced learning and memory impairment in rats","volume":"157","author":"Kooshki","year":"2016","journal-title":"Physiol Behav"},{"issue":"32","key":"10.1016\/j.sleep.2025.106633_bib52","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.2174\/0929867324666170529072554","article-title":"The orexinergic (hypocretin) system and nociception: an update to supraspinal mechanisms","volume":"25","author":"Roohbakhsh","year":"2018","journal-title":"Curr Med Chem"},{"issue":"9","key":"10.1016\/j.sleep.2025.106633_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/03331024241281493","article-title":"A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache","volume":"44","author":"Kopruszinski","year":"2024","journal-title":"Cephalalgia"},{"key":"10.1016\/j.sleep.2025.106633_bib54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2015.08.001","article-title":"Orexin-A modulates excitatory synaptic transmission and neuronal excitability in the spinal cord substantia gelatinosa","volume":"604","author":"Jeon","year":"2015","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2018.04.182","article-title":"Modulation by orexin A of spontaneous excitatory and inhibitory transmission in adult rat spinal substantia gelatinosa neurons","volume":"501","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sleep.2025.106633_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pharmthera.2017.12.010","article-title":"Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders","volume":"186","author":"Tsuneki","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"7063","key":"10.1016\/j.sleep.2025.106633_bib57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/papr.13149","article-title":"Circadian pain patterns in human pain conditions - a systematic review","volume":"23","author":"Knezevic","year":"2023","journal-title":"Pain Pract"},{"issue":"5","key":"10.1016\/j.sleep.2025.106633_bib59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41386-020-0619-x","article-title":"Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?","volume":"45","author":"James","year":"2020","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.sleep.2025.106633_bib60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-444-59489-1.00007-0","article-title":"Multiple roles for orexin\/hypocretin in addiction","volume":"198","author":"Mahler","year":"2012","journal-title":"Prog Brain Res"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib61","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41398-022-02161-z","article-title":"Oxytocin and orexin systems bidirectionally regulate the ability of opioid cues to bias reward seeking","volume":"12","author":"Giannotti","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.sleep.2025.106633_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109685","article-title":"Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement","volume":"239","author":"Illenberger","year":"2023","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.sleep.2025.106633_bib63","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00213-023-06320-y","article-title":"The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act","volume":"240","author":"Moline","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.sleep.2025.106633_bib64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib65","first-page":"57","article-title":"A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea","volume":"20","author":"Cheng","year":"2024","journal-title":"J Clin Sleep Med : JCSM : official publication of the American Academy of Sleep Medicine"},{"key":"10.1016\/j.sleep.2025.106633_bib66","article-title":"The efficacy and safety of dual orexin receptor antagonists in obstructive sleep apnea: a systematic review and meta-analysis of randomised controlled trials","author":"Yeh","year":"2024","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.sleep.2025.106633_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40263-023-01055-y","article-title":"Treatment of sleep, motor and sensory symptoms with the orexin antagonist suvorexant in adults with idiopathic restless legs syndrome: a randomized double-blind crossover proof-of-concept study","volume":"38","author":"Garcia-Borreguero","year":"2024","journal-title":"CNS Drugs"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725003089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725003089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T20:00:43Z","timestamp":1754510443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725003089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":67,"alternative-id":["S1389945725003089"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106633","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The putative effects of orexin receptor antagonists on pain and sleep in humans: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106633"}}